What is Livzon Pharmaceutical Group Cash Flow from Financing?
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Mar. 2024,
Livzon Pharmaceutical Group paid¥0 Mil more to buy back shares than it received from issuing new shares.
It spent¥577 Mil paying down its debt.
It paid¥0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It spent¥23 Mil paying cash dividends to shareholders.
It spent¥55 Mil on other financial activities.
In all, Livzon Pharmaceutical Groupspent¥655 Mil on financial activities for the
three
months ended in Mar. 2024.
Livzon Pharmaceutical Group Cash Flow from Financing Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Livzon Pharmaceutical Group Cash Flow from Financing Chart
Livzon Pharmaceutical Group Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Livzon Pharmaceutical Group's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-2,628 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Livzon Pharmaceutical Group (SZSE:000513) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Livzon Pharmaceutical Group's issuance of stock for the
three
months ended in Mar. 2024 was ¥0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Livzon Pharmaceutical Group's repurchase of stock for the
three
months ended in Mar. 2024 was ¥0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Livzon Pharmaceutical Group's net issuance of debt for the
three
months ended in Mar. 2024 was ¥-577 Mil.
Livzon Pharmaceutical Group spent¥577 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Livzon Pharmaceutical Group's net issuance of preferred for the
three
months ended in Mar. 2024 was ¥0 Mil.
Livzon Pharmaceutical Group paid¥0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Livzon Pharmaceutical Group's cash flow for dividends for the
three
months ended in Mar. 2024 was ¥-23 Mil.
Livzon Pharmaceutical Group spent¥23 Mil paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Livzon Pharmaceutical Group's other financing for the
three
months ended in Mar. 2024 was ¥-55 Mil.
Livzon Pharmaceutical Group spent¥55 Mil on other financial activities.
Livzon Pharmaceutical Group Cash Flow from Financing Related Terms
Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
Livzon Pharmaceutical Group (SZSE:000513) Business Description
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.
Livzon Pharmaceutical Group (SZSE:000513) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:000513 has been successfully added to your 